Abstract
Binge eating (BE) is a heritable symptom of eating disorders associated with anxiety, depression, malnutrition, and obesity. Genetic analysis of BE could facilitate therapeutic discovery. We used an intermittent, limited access BE paradigm involving sweetened palatable food (PF) to examine genetic differences in BE, conditioned food reward, and compulsive-like eating between C57BL/6J (B6J) and DBA/2J (D2J) inbred mouse strains. D2J mice showed a robust escalation in intake and conditioned place preference for the PF -paired side. D2J mice also showed a unique style of compulsive-like eating in the light/dark conflict test where they rapidly hoarded and consumed PF in the preferred unlit environment. BE and compulsive-like eating exhibited narrow-sense heritability estimates between 56 and 73 percent. To gain insight into the genetic basis, we phenotyped and genotyped a small cohort of 133 B6J x D2J-F2 mice at the peak location of three quantitative trait loci (QTL) previously identified in F2 mice for sweet taste (chromosome 4: 156 Mb), bitter taste (chromosome 6: 133 Mb) and behavioral sensitivity to drugs of abuse (chromosome 11: 50 Mb). The D2J allele on chromosome 6 was associated with greater PF intake on training days and greater compulsive-like PF intake, but only in males, suggesting that decreased bitter taste may increase BE in males. The D2J allele on chromosome 11 was associated with an increase in final PF intake and slope of escalation across days. Future studies employing larger crosses and genetic reference panels comprising B6J and D2J alleles will identify causal genes and neurobiological mechanisms.
Keywords: GWAS, hoarding, QTL, sex differences, sucrose, TAS2R
1. INTRODUCTION
Eating disorders (ED) are the most lethal of all psychiatric disorders, with high mortality rates and lifetime prevalence rates ranging from 1–3% [1]. ED and related behaviors, including binge eating (BE) are heritable; however, the genetic basis of ED and BE remain largely unknown [2]. BE can be observed in all three major EDs, including Binge Eating Disorder (BED), Bulimia Nervosa (BN), and Anorexia Nervosa (AN) [3, 4]. BE is defined by the compulsive/unrestrained consumption of an extraordinarily large amount of food (typically palatable food with a high caloric content) within a brief time period and is accompanied by a sense of loss of control as well as feelings of uncomfortable fullness, distress, disgust, anxiety, depression, guilt, and remorse [5]. BE is also associated with hoarding behavior [6], including hoarding of food so that it can be consumed alone [7]. BE is associated with multiple health issues, including mood dysfunction, aberrant eating patterns and cycles of BE and food restriction, malnutrition, and obesity-related health issues [8]. BE can be extinguished in humans and in preclinical models [9, 10]; however, there is a high rate of rapid and long-term relapse [11, 12].
Potential pharmacotherapeutic treatment options for BE have had limited success. The only FDA-approved drug for the treatment of moderate-to-severe BED is Lisdexamfetamine dimesylate, an amphetamine prodrug with limited, long-term efficacy and a high risk of abuse potential and adverse side effects such as dry mouth, insomnia, headaches, nausea, and increased heart rate [13–15]. Accordingly, although lisdexamfetamine is not prescribed to patients with a known history of Substance Use Disorders, treating BE-presenting patients with amphetamines could be problematic, given the high degree of comorbidity and shared neurobiological mechanisms between BE and substance use disorders [16, 17]. Clearly, more efficacious treatments with fewer side effects are needed.
Very few genome-wide forward genetic (linkage or GWAS) studies have been conducted for BE or BED in humans [18] or in preclinical models [19]. In rodents, BE in non-stressed, non-food-deprived animals is most readily achieved under a specific set of conditions that includes 1) presentation of palatable food (e.g., sweetened or high fat), 2) limited access (e.g., 0–2 h), and 3) intermittent access [20, 21]. We recently utilized these conditions to conduct a genome-wide quantitative trait locus (QTL) study of BE between closely related C57BL/6 substrains and mapped and validated cytoplasmic FMR1-interacting protein 2 (Cyfip2) as a major genetic factor underlying BE [19]. Owing to the drastically reduced genetic complexity of this cross, BE exhibited a simple Mendelian inheritance, yielding a single locus explaining the parental strain (genetic) variance in BE [19]. This highlights both a main advantage and disadvantage of utilizing reduced complexity crosses for forward genetic studies of complex traits. One the one hand, reduced genetic complexity can quickly lead to identification of the underlying genetic factors responsible for behavioral trait variation [19, 22–24]. On the other hand, complex traits in a reduced complexity cross are expected to segregate phenotypic variance in a near-Mendelian fashion and thus, only one major locus/gene is likely to account for most of the genetic variation in a complex trait [19, 23, 24]. Ultimately, populations of increasing complexity must be employed to understand the genetic basis of complex traits such as BE.
C57BL/6J (B6J) and DBA/2J (D2J) are two of the most widely used inbred strains in orward genetic studies of complex traits, largely because they are the original parental strains of one of the largest and most widely used set of murine recombinant inbred (RI) strains for dissecting the genetic basis of neurobehavioral traits - the BXD RI panel [25]. A heritable strain difference in BE and associated behaviors between B6J and D2J provides the foundation for future use of the BXD RI panel in a systems genetics approach to advance our knowledge regarding the preclinical genetic and neurobiological basis of BE and ultimately translate these findings to humans.
To facilitate the long-term goal of conducting genetic mapping studies in additional crosses and panels, in the present study, we assessed mouse inbred strain differences in BE of sweetened palatable food (PF) and concomitant behaviors between the BE-resistant B6J strain [19, 26] and the D2J strain. The D2J strain has previously been shown to exhibit either less or more consumption of sweetened solutions relative to the B6J strain, depending on the duration of access and the concentration of solution [27–32]. We next estimated narrow-sense heritability of 16 BE-related traits. To provide further evidence for a genetic basis for BE, we phenotyped a small cohort of 133 B6JxD2J-F2 mice (F2) and genotyped these mice at markers targeting three QTLs, including a first QTL associated with sweet taste (chromosome 4: 156 Mb) [27, 32, 33]), a second QTL associated with bitter taste (chromosome 6: 133 Mb) [27, 34], and a third QTL (chromosome 11: 50 Mb) associated with sensitivity the psychomotor stimulant effects of methamphetamine [35] and cocaine [23]. These QTLs were hypothesized to be potentially important for BE, given that taste influences food palatability and given that QTLs associated with the behavioral effects of drugs of abuse could potentially exert pleiotropic effects on the hedonic aspects of palatable food consumption [19, 23, 36].
2. METHODS AND MATERIALS
2.1. Mice
All experiments were conducted in accordance with the NIH Guidelines for the Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at Boston University. Mice were maintained on a 12 h /12 h light/dark cycle (lights on at 0630 h) and housed two to four animals per cage in same-sex cages. Laboratory chow (Teklad 18% Protein Diet, Envigo, Indianapolis, IN, USA) and tap water were available ad libitum in home cages. Testing was conducted during the light phase. C57BL/6J (B6J), DBA/2J (D2J) and B6JxD2J-F1 mice (7 weeks old) were purchased from the Jackson Laboratory (JAX; Bar Harbor, ME) and were generated at JAX by crossing B6J males with D2J females. Purchased mice were habituated to the vivarium one week before testing in a separate room. B6JxD2J-F2 (N=133) mice were generated in-house by pairing the F1 mice. Mice were between 50 and 100 days old on the first day of training.
2.2. PF and chow pellets
PF pellets were purchased from TestDiet (20 mg each; 5TUL diet; MO, USA). The 5TUL contains a metabolizable energy density of 3.4 kcal/g (21% from protein, 13% from fat, and 67% from carbohydrates). Chow pellets were custom- made in the 20 mg size by Purina LabDiet to closely resemble the home cage diet in the vivarium (Teklad 18% Protein Diet) and represent the LabDiet 5V75 formulation which contains a metabolizable energy density of 3.26 kcal/g (calories provided: 23% from protein, 13% from fat, and 64% from carbohydrates). Additional information for the 5TUL and 5V75 diets can be found online at the TestDiet website (https://www.testdiet.com/) and the LabDiet website (https://www.labdiet.com/).
2.3. Behavioral testing
2.3.1. BE, CPP, and the light/dark conflict test of compulsive-like eating
On Day (D)1, mice were assessed for initial preference for the food-paired side (the right side) by placing the mice into the left side, providing open access (5 cm x 6.5 cm) to both sides for 30 min, and video recording initial time spent on the food-paired side. On training D2, D4, D9, D11, D16, and D18, mice were restricted to the right side of the apparatus (pointed floor texture) and given access to 40 sweetened PF pellets (20 mg each, 5TUL diet, Test Diet, MO, USA) or 40 unsweetened Chow pellets (20 mg each, 5BR3 Test Diet, MO, USA) of a similar size and weight for 30 min. Food pellets were weighed before and after the 30-min period. In contrast, on training D3, D5, D10, D12, D17, and D19, mice were restricted to the left side (smooth-textured floor) with an empty bowl for 30 min. On D22, mice were assessed for final side preference by placing the mice in the left side and providing open access. BE was operationally defined in our model as significantly greater consumption of palatable food acutely and over the course of the study compared to Chow. Differences in the degree of binge eating were detected as group differences in PF intake across time and by differences in the slope of escalation of intake across time [19, 37]. Food intake was quantified as percent body weight (BW) consumed [grams (g) food consumed / body weight (g) * 100].
On D23, we used the light/dark conflict test to assess compulsive-like eating and concomitant behaviors [19]. Briefly, light/dark boxes had two chambers (20 cm x 40 cm) connected by a small entryway. The dark, unlit, normally preferred chamber had black, opaque sides and a top and bordered the clear, light-exposed, aversive side. A white porcelain bowl containing PF was secured to the middle of the light side floor. Because rodents show a natural aversion for light, compulsive-like eating was operationalized as the intake of PF in the light side [19]. Additional non-ingestive compulsive behaviors were recorded using AnyMaze video tracking software (Stoelting, Wood Dale, IL, USA). Only a subset of data from the Chow- trained D2J group on D23 were available for analysis (n=12/23 total samples).
2.3.2. Behavioral testing in B6J x D2J-F2 mice
We phenotyped a total of 133 F2 mice (68 females, 65 males) in our intermittent, limited access, CPP paradigm. A subset of 93 of these mice (43 females, 50 males), were tested in a battery of premorbid compulsive- and anxiety-like behaviors over one week prior to PF training. F2 mice were genotyped for SNPs located at three historic B6J/D2J-derived quantitative trait loci (QTLs): a chromosome 4 QTL associated with sweet taste within the Tas1r3 gene (rs6316711; 156 Mb; [38]), a chromosome 6 QTL associated with bitter taste within the Tas2r110 gene (rs13479039; 133 Mb; [34]), and a third QTL on chromosome 11 associated with behavioral sensitivity to methamphetamine and cocaine upstream of the Hnrnphl gene (rs29383600; 50 Mb) [35, 39, 40].
2.3.3. Premorbid compulsive- and anxiety- like behaviors B6J x D2J-F2mice.
Because of the link between anxiety, compulsivity and pathological overeating [41] and because obsessive-compulsive behavior is associated with eating disorders [42, 43], following the identification of parental strain differences in BE, we developed a behavioral battery to assess differences in premorbid anxiety-like and compulsive-like behaviors [44] that we applied toward experimentally naïve F2 mice. A subset of the F2 mice we generated (92 out of 132 mice total) were tested in the behavioral battery during the first week of testing with one test per day over five days in the following order: 1) open field; 2) elevated plus maze; 3) marble burying; 4) hole board; 5) y-maze. Procedural details are provided in the Supplementary Information. The following week, training commenced for the BE protocol.
2.4. Genotyping in B6J x D2J-F2 mice
SNP genotyping was performed at the three loci on chromosomes 4, 6, and 11 described above using fluorescent markers (Life Technologies, Carlsbad, CA USA) and a StepOne machine (Applied Biosystems, Foster City, CA USA).
2.5. Statistical analyses
2.5.1. Behavioral analysis of BE in B6J, D2J, B6J x D2J-F1, and B6J x D2J-F2 mice
B6J and D2J mice were tested in a 2 × 2 factorial design to examine PF or Chow intake as a function of Genotype (Strain). Data analysis was conducted in R (https://www.r-project.org/). Food intake [percent body weight consumed: grams (g) consumed / mouse body weight (g)* 100], CPP (time spent on the food side pre- versus post-training), compulsive-like eating (PF intake on D23 normalized to body weight), and behavior (percent time spent in light, number of entries to light, number of freezing episodes in light, and mean visit time) were analyzed using mixed-model ANOVA (Genotype, Treatment, and Sex as independent variables; Day as a repeated measure). Post hoc one- or two-way ANOVA and Welch’s unequal variances t tests were also conducted to determine effects on individual days.
Bonferroni-adjusted p-values for statistical significance were used as follows: For pairwise group comparisons of consumption across the six food training days: p < 0.05/6 (αadjusted = 0.0083); for pairwise Sex comparisons involving summed intake, change in body weight, and D1 versus D22 for conditioned place preference: p < 0.05/4 (αadjusted = 0.0125); for comparing a single group to three other groups in slope analysis: p < 0.05/3 (αadjusted = 0.0167); for the six possible comparisons in the compulsive-like eating test and for p < 0.05/6 (αadjusted = 0.0083); for the six possible comparisons between B6J, D2J, F1, and F2 mice in the compulsive-like eating test: p < 0.05/6 (αadjusted = 0.0083); for the three possible comparisons across QTL genotypes in examining compulsive-like intake: p < 0.05/3 (αadjusted = 0.0167).
Slope analysis of normalized food intake across the food training days was conducted to quantify escalation [19, 26, 37, 44]. Due to a video recording failure caused by insufficient computer storage space, non-ingestive behaviors (time on, number of visits to, and mean visit time on the light side) on D23 were not obtained in 8 of the 16 PF-trained F1 mice. Therefore, data from only 8 F1 PF- trained mice are reported for the non-ingestive D23 phenotypes.
2.5.2. Heritability estimates of BE and concomitant phenotypes
Narrow-sense heritability (h2) was estimated using the between-strain variance (genetic variance; VG) and the average within-strain variance (environmental variance; VE) of the parental strains and F1 mice for each phenotype and then calculating the percentage of the total phenotypic variance (VG+VE) accounted for by VG (i.e., heritability) according to the following formula: h2 = VG/(VG+VE) *100 [45, 46]. This analysis is based on the fact that individuals within a strain are genetically identical and thus, any difference within a strain is assumed to be due to environmental effects and any difference between strains is assumed to be due to genetic differences. This analysis does not account for non-additive variance explained by gene x environment or gene x gene interactions. In cases where we identified statistically significant effects of Genotype, we report percent phenotypic variance accounted for (i.e., h2 explained) at the chromosomal locus by dividing the genetic variance between genotypes at the particular locus (marker) by the total phenotypic variance in F2 mice. Percent genetic variance explained by a given locus for a trait was calculated by dividing the genetic variance of the locus by the genetic variance of the trait.
2.5.3. Correlation matrices and exploratory factor analysis
To examine the correlation among the major behavioral phenotypes, correlation matrices of variables collected in PF -trained B6J, D2J, and B6J x D2J- F2 mice were generated in R using the “rcorr” function from the package “Hmisc.” This function employed Spearman’s rank pairwise correlations across 16 behavioral variables. To reduce the dimensionality of the data and potentially uncover novel relationships, we conducted exploratory factor analysis [47]. This analysis was conducted using the R package “psych” using the “factanal” function. We used the “Varimax” function for orthogonal rotation of the matrix, yielding a simpler data structure that most efficiently loaded each variable onto the fewest number of factors as possible. Factors with eigenvalues greater than one were included in the analysis. Chi square tests were used to determine an optimal number of factors to explain the variance. Additionally, in a subset of the F2 mice, we conducted a separate factor analysis in order to determine if premorbid compulsive- and anxiety-like behaviors related to BE behaviors. Because this analysis revealed no loadings between premorbid compulsive-like phenotypes and BE phenotypes, we conducted separate factor analyses for the group of premorbid versus compulsive-like variables.
2.5.4. Power analysis.
We used the freely available G*Power 3 program (http://www.gpower.hhu.de/en.html) to conduct power analyses. A complete description of the statistical procedures used in G*Power has been published [48]. We used the statistical test, “Means: Difference between two independent means (two groups)”, to conduct the various power analyses, including observed effect sizes, required sample sizes, and achieved power. We used the means and standard deviations of the parental B6J and D2J strains or the homozygous B6J and D2J genotypes to calculate the effect sizes (Cohen’s d) for differences in PF intake across training days. In deciding on a sample size for the F2 cross, we first assumed an average effect size for a given locus (d = 0.5). We then selected the power analysis entitled, “A priori: Compute required sample size - given alpha, power, and effect size”, to calculate the required sample size of homozygous B6J and D2J genotypes to achieve 80% power (p < 0.05; two-tailed test). Finally, we assumed a 1:2:1 Mendelian ratio of offspring genotypes derived from F1 x F1 (heterozygous-heterozygous) breeding in deciding how many F2 mice would need to be generated in order to obtain a sufficient number of homozygous genotypes. To calculate achieved power at each of the two significant loci, we selected the power analysis entitled, “Post hoc: Compute achieved power - given alpha, sample size, and effect size”, and used the observed sample sizes and the observed effect size of the two homozygous genotypes (p < 0.05; two-tailed test). Because we did not have a priori knowledge of the mode of inheritance at each locus and because we tested a small number of F2 mice, we did not include heterozygous phenotypes in this analysis which yielded more conservative estimates of achieved power and required sample sizes.
3. RESULTS
3.1. BE and CPP in B6J and D2J strains
In examining strain differences in BE behaviors in a CPP paradigm (Fig. 1A), D2J mice trained with PF (n = 24; 14 females, 10 males) showed greater food intake than D2J mice trained with Chow (n = 23; 9 females/14 males), B6J PF (n = 24; 12 females/12 males), and B6J Chow groups (n = 24; 12 females/12 males; main effects of Treatment and Genotype with follow-up two-way two-way ANOVAs and post-hoc t-tests for each training day; Fig. 1B). Both PF-trained D2J and B6J mice consumed more food than either Chow-trained group on all food days except day (D)9 for B6J (Fig. 1B). D2J females exhibited an overall higher summed normalized food intake (i.e., total percent body weight consumed of PF or chow across all six training days involving food - Days 2, 4, 9, 11, 16, and 18) than males, regardless of the food type (Genotype x Treatment and Genotype x Sex interaction with post hoc t-tests; Fig. 1C). Examination of the slopes of escalation in normalized food intake over the course of the study revealed that the B6J PF, D2J PF, and D2J Chow groups all escalated their intake (Fig. 1D). PF-trained D2J mice clearly exhibited the most robust escalation in intake as reflected by the largest slope (Fig. 1D).
The relationship between intake of a particular diet and percent changes in body weight across Training Days was complex. Chow-trained D2J mice displayed the highest percent change in body weight compared to all other groups (Fig. 1E; Fig. S2) yet displayed much less food intake than the D2J PF group during BE training (Fig. 1B). Generally speaking, although PF-trained mice consumed more food during the BE training sessions, they showed less % increase in body weight than those trained with Chow. A lower percent increase in body weight could result from decreased home cage chow intake and thus, decreased caloric intake, perhaps in anticipation of the more preferred PF, as has been previously reported [20, 49, 50]. Alternatively, it could mean that there is greater energy expenditure in the home cage. Finally, although female D2J mice showed the greatest amount of food consumed for each Treatment (Fig. 1C), they actually showed much less % increase in body weight than their male D2J counterparts (Genotype x Sex and Genotype x Treatment x Sex interactions with post hoc t-tests; Fig. 1E).
To examine genetic differences in conditioned food seeking behavior, we compared the time spent on the food-paired side of the CPP box during open access on D22 with the initial time spent on D1. Corresponding with the increased BE observed in PF-trained D2J mice (Fig. 1B), these mice also displayed an increase in time spent on the food-paired side of the CPP box on D22 versus D1 (Genotype x Day interaction with post hoc t-test; Fig. 1F). Thus, D2J mice show both increased BE and increased conditioned reward for PF.
3.2. Compulsive-like eating and concomitant behaviors in B6J and D2J strains
Following assessment of conditioned food seeking behavior on D22, on D23 we assessed compulsive-like food seeking in the light/dark conflict test whereby all groups were provided access to PF located in the normally aversive light side of the light/dark box, thus creating a conflict (Fig. 2A). PF-trained D2J mice exhibited much greater compulsive-like eating than all other groups (main effects of Genotype and Treatment and Genotype x Treatment interaction with post hoc t- tests; Fig. 2B), consistent with an association between BE during training and compulsive-like eating. However, despite the increase in compulsive-like eating, D2J mice actually spent less time in the light side of the light/dark box (main effect of Genotype; Fig. 2C), and showed fewer entries into the light side (main effect of Genotype; Fig. 2D), as well as an increase in the number of freezing episodes (main effect of Genotype; Fig. 2E), and a shorter mean visit time in the light side (main effect of Genotype; Fig. 2F) than B6J mice. No differences in avoidance/anxietylike behavior were found between treatment groups of each strain (padjusted > 0.0125; Fig. 2C-F), indicating that the increased avoidance/anxiety-like behaviors in D2J mice is driven by a stable, pre-existing genetic difference that is resistant to competing consummatory behavior. Of note, the DBA/2 strain is known to exhibit a high level of anxiety-like behavior in multiple assays, including light/dark, zero maze, and open field [51] and QTLs have been identified for anxiety-related traits in B6J x D2J-F2 [52] and BXD RI strains [25] indicating that strain differences in anxiety-like traits are heritable and controlled by specific genetic factors.
The behavioral repertoire of compulsive-like eating in PF-trained D2J mice was in stark contrast to a recent genetic model of BE that we reported, where we found a positive, rather than negative, relationship between compulsive eating and concomitant compulsive behaviors in the BE-prone C57BL/6NJ strain [19]. Thus, PF-trained D2J mice managed to preserve their innate behavioral avoidance of light while efficiently managing to consume large amounts of PF. These results suggested a unique style of compulsive-like eating that involved a rapid entry and PF retrieval, followed by a quick retreat to the dark side where the PF was consumed. In support, D2J mice consumed a significantly greater number of pellets per visit versus B6J mice and indeed, video recording of the side view of the light side provided confirmation of an acquire-retreat-acquire-retreat strategy in D2J mice (Fig. 3 & Supplementary Information). These findings were consistent regardless of Sex, in that both female and male D2J mice consumed more pellets per visit that B6J mice (data not shown).
3.3. Effect sizes and power analysis
The effect size for differences in PF intake between B6J and D2J strains for Day 2 through Day 18 were quite high and increased across training days (Cohen’s d = 1.23, 1.58, 1.75, 2.28, 2.32, 2.89). In considering how many B6J x D2J-F2 mice to test in order to detect an effect of our three candidate loci, we assumed a much smaller medium effect size of d = 0.5 for each of our three candidate loci, resulting in a required sample size of n = 64 per homozygous genotype to achieve 80% power (p < 0.05). Assuming 1:2:1 Mendelian ratios, n = 64 per homozygous genotype equates to generating 256 F2 mice. Because this arm of the study was a preliminary investigation into the feasibility of conducting a genome-wide QTL analysis, we tested approximately one-half of this sample size (N = 133) which provided us with 52% power to detect the effect of a locus with medium-effect size (d = 0.5; p < 0 .05, two-tailed test), assuming a Mendelian ratio and thus, a sample size yielding n = 33 per homozygous genotype.
3.4. Heritability estimates for BE and concomitant behaviors based on the results of the parental B6J and D2J strains
We estimated heritability (h2) of 16 BE- and CPP-related variables collected from PF-trained mice (Table S1). The most heritable phenotypes were related to PF intake. Specifically, normalized PF intake on D2, D18, and D23 in the light/dark apparatus exhibited heritability estimates of 34%, 56%, and 73%, respectively. Conversely, non-ingestive behaviors in the light/dark apparatus were the least heritable, with time in the light, number of entries into the light, and distance in the light exhibiting much lower heritability estimates ranging from 1 to 10%. Intermediately heritable phenotypes included those related to conditioned locomotor behaviors in the PF-paired side of the CPP apparatus, including D22 distance on the food side (28%), D22 entries into the food side (18%), and D22 entries into the food triangle (22%).
3.5. Phenotypic comparison of F1and F2 mice with the B6J and D2J parental strains
On the first food training day, the D2J strain consumed the most PF whereas F1, F2, and B6J mice consumed a similar level (main effect of Genotype with post hoc t-tests; Fig. S1A). The D2J strain also showed the largest PF intake and the greatest slope of escalation compared to all groups on all days of the study (main effect of Genotype and Genotype x Day interaction with post hoc t-tests; Fig. S1A). F1 and F2 mice showed slopes of escalation in PF intake that were intermediate between the D2J and B6J strains (Fig. S1A). F2 mice showed a level of intake that was intermediate between B6J and D2J on D9, 11, 16, and 18. However, F1 mice showed significantly greater intake than B6J only on the final training day (D18; Fig. S1A). F2 mice also showed greater summed PF intake (%BW consumed, summed across all six training days - D2, D4, D9, D11, D16, and D18) that B6J. F1 mice did not show any difference relative to B6J Fig. S1A), likely due to the small sample size. D2J mice also showed the largest amount of compulsive-like PF intake compared to the other three groups which did not differ from each other (main effect of Genotype with post hoc tests; Fig. S1A). To summarize, the phenotypic effect of the B6J allele was dominant with regard to low level of initial and compulsive-like PF intake, the D2J allele dominated with regard to escalation in PF intake, and the mode of inheritance was additive with regard to intake on later training days. These observations provide evidence that different genetic factors could mediate different aspects of BE.
3.6. Female and male analyses of D2J versus B6J strain differences in PF intake and compulsive-like eating
We next report strain differences separately for females and males in order to facilitate the later comparison of this data with the data showing sex-specific genetic loci. Qualitatively similar effects were observed in both sexes. In both females and males PF-trained mice showed greater intake compared to Chow- trained mice (Fig. 4A,D). Moreover, regardless of Sex, PF-trained D2J mice showed the most robust escalation in food intake (Fig. 4B,E), and the greatest compulsive-like PF intake (Fig. 4C,F). Chow-trained female D2J mice showed a significant escalation in consumption whereas Chow-trained male D2J mice did not (Fig. 4B,E), indicating less specificity for BE of PF in female D2J mice.
3.7. Genotypic analysis of candidate loci on chrs. 4, 6, and 11 in BE and compulsive-like eating
To provide initial insight into the genetic basis underlying the parental B6J and D2J strain differences in BE, we tested a small cohort of B6J x D2J F2 mice. Mice were genotyped at the peak locations of three different QTLs (see Methods) previously associated with sweet taste (chr. 4; rs6316711, 156 Mb), bitter taste (chr. 6; rs13479039; 133 Mb), and sensitivity to drugs of abuse (chr. 11; rs 29383600; 50 Mb). For the sweet taste locus on chromosome 4, we did not identify any significant effect of Genotype on PF intake over time (Fig. 5A), on slope of escalation of intake (Fig. 5B), or on compulsive-like PF intake in the light/dark apparatus (Fig. 5C).
For the bitter taste locus on chromosome 6, mice homozygous for the D2J allele showed a significant increase in PF intake on D9 and D16 relative to mice homozygous for the B6J allele (D2J vs. B6J; main effect of Genotype with post hoc t-tests for each Day; Fig. 5D). The effect sizes for D9 intake and D16 intake were derived from the two homozygous genotypes as described in the Methods and were d = 0.48 and 0.7, respectively. With these effect sizes and a sample size of n = 38 B6J and n = 39 D2J, we achieved 55% and 86% power, respectively (p < 0.05). The chromosome 6 locus explained 5% and 11% of the phenotypic variance in PF intake on D9 and D16. The h2 of D9 and D16 phenotypes was 43% and 57%, respectively (Table 1). There was no effect of Genotype on the slope of escalation (Fig. 5E). For compulsive-like intake, mice homozygous for D2J consumed more PF than mice homozygous for B6J (Fig. 5F). The h2 of compulsive-like eating was 69% and the chromosome 6 locus explained 7% of the phenotypic variance and 3% of the genetic variance in compulsive-like eating (Table 1).
Table 1.
Females + Males | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chromosome 6 |
Chromosome 11 |
||||||||||||||||
2 | 4 | 9 | 11 | 16 | 18 | slope | L/D | 2 | 4 | 9 | 11 | 16 | 18 | slope | L/D | ||
Parental | |||||||||||||||||
h2 | 27% | 39% | 43% | 57% | 57% | 68% | 41% | 69% | 27% | 39% | 43% | 57% | 57% | 68% | 41% | 69% | |
% Phen. | |||||||||||||||||
Var. | |||||||||||||||||
Explained | 0% | 0% | 5% | 3% | 11% | 4% | 8% | 7% | 1% | 0% | 1% | 2% | 5% | 8% | 19% | 3% | |
% Gen. | |||||||||||||||||
Var. | |||||||||||||||||
Explained | 0% | 0% | 5% | 2% | 10% | 11% | 2% | 3% | 4% | 0% | 1% | 2% | 6% | 8% | 26% | 2% | |
Females | |||||||||||||||||
Chromosome 6 |
Chromosome 11 |
||||||||||||||||
2 | 4 | 9 | 11 | 16 | 18 | slope | L/D | 2 | 4 | 9 | 11 | 16 | 18 | slope | L/D | ||
Parental | |||||||||||||||||
h2 | 54% | 59% | 59% | 78% | 72% | 75% | 33% | 78% | 54% | 59% | 59% | 78% | 72% | 75% | 33% | 78% | |
% Phen. | 6% | 12% | 0% | 15% | 1% | 1% | 6% | 12% | 1% | 0% | 1% | 3% | 3% | 5% | 12% | 1% | |
Var. | |||||||||||||||||
Explained | |||||||||||||||||
% Gen. | |||||||||||||||||
Var. | |||||||||||||||||
Explained | 11% | 20% | 0% | 19% | 1% | 2% | 18% | 15% | 2% | 1% | 3% | 3% | 4% | 7% | 36% | 1% | |
Males | |||||||||||||||||
Chromosome 6 |
Chromosome 11 |
||||||||||||||||
2 | 4 | 9 | 11 | 16 | 18 | slope | L/D | 2 | 4 | 9 | 11 | 16 | 18 | slope | L/D | ||
Parental | |||||||||||||||||
h2 | 4% | 17% |
24% | 35% | 39% | 56% | 53% | 58% | 4% | 17% | 24% | 35% | 39% | 56% | 53% | 58% | |
% Phen. | |||||||||||||||||
Var. | |||||||||||||||||
Explained | 3% | 2% | 14% | 9% | 21% | 18% | 14% | 35% | 2% | 0% | 0% | 2% | 14% | 13% | 39% | 11% | |
% Gen. | |||||||||||||||||
Var. | |||||||||||||||||
Explained | 84% | 10% | 58% | 25% | 55% | 31% | 26% | 60% | 59% | 0% | 1% | 5% | 36% | 23% | 72% | 19% |
Highlighted cells correspond to significant differences in phenotype in the F2 mice.
For the locus influencing sensitivity to drugs of abuse on chromosome 11, mice homozygous for D2J consumed more PF than mice homozygous for B6J on D18 (main effect of Genotype; Fig. 5G). The effect size of D18 intake based on the two homozygous genotypes was d = 0.58. With this effect size and with a sample size of n = 32 homozygous B6J and n = 27 homozygous D2J genotypes at this locus, we achieved 59% power (p < 0.05). The h2 of D18 intake was 68% and the chromosome 11 locus (50 Mb) explained 8% of the phenotypic variance and 8% of the genetic variance in D18 PF intake (Table 1). Mice homozygous for D2J also showed a greater slope of escalation in PF intake compared to mice homozygous for B6J (Fig. 5H), but no difference in compulsive-like PF intake (Fig. 5I). The h2 of the slope of PF intake was 41% and the chromosome 11 locus explained 19% of the phenotypic variance and 26% of the genetic variance (Table 1).
3.8. Male-specific effect of the bitter taste locus on chromosome 6
When we considered the effect of Genotype at chromosome 6 separately in each sex, for females, there was no effect of Genotype on PF intake (Fig. 6A-C). In contrast, males completely accounted for the observed effect in which mice homozygous for the D2J allele showed greater PF intake on D9, D16, and D18 (main effect of Genotype with post hoc t-tests for each Day; Fig. 6D), a greater slope of escalation (Fig. 6E), and a greater compulsive-like PF intake (main effect of Genotype with post hoc t-tests; Fig. 6F) relative to males homozygous for the B6J allele. The h2 of the significant male-specific phenotypes - D9, D16, D18, and compulsive-like consumption - was 24%, 39%, 57%, and 58% (Table 1). The percent phenotypic variance explained at the chromosome 6 locus for these four male-specific phenotypes was 14%, 21%, 18%, and 35% and the percent genetic variance explained was 58%, 55%, 31%, and 60% (Table 1). Thus, the chromosome 6 locus is a major, male-specific locus influencing BE.
3.9. Chromosome 11 locus: females versus males
For females, the effect of Genotype on PF intake at the chromosome 11 locus was not significant during training or compulsive-like assessment (Fig. 6G-I). For males, mice homozygous for the D2J allele showed a significant increase in slope of escalation of PF intake relative to mice homozygous for the B6J allele (Fig. 6K,L), thus accounting for the overall effect of Genotype in Fig. 5H. The h2 of this trait was 53% in males and the chromosome 11 locus explained 39% of the phenotypic variance and 73% of the genetic variance in the slope of escalation in PF intake (Table 1).
3.10. Exploratory factor analysis of BE and compulsive eating in B6J, D2J, and F2 mice
To reveal potential novel relationships among the 16 major BE- and CPP- related variables, we conducted exploratory factor analysis in PF-trained B6J, D2J, and F2 mice (Table S1). The top three factors for each group are color coded according to shared variables for each factor (not according to percent variance explained). Here, we discuss variables with factor loadings of 0.4 or greater. For the B6J strain (Fig. 7A), three factors explained 55% of the total variance [χ2 (88, N = 24) = 158.8; p = 5.7 × 10−6]. For the D2J strain (Fig. 7B), three factors explained 57% of the variance [χ2 (88, N = 24) = 155.2; p = 1.3 × 10−5].
The blue factor explained 19% of the variance in both B6J mice and D2J mice. We termed this factor “Food Seeking Activity” for both strains, as it encompassed four variables related to activity during CPP assessment on D22 (#7, #9, #10, and #12), including D22 Entries to the Food Side (#7), D22 Distance on the Food Side (#9), D22 Entries to the Food Triangle (#10), and D22 Distance in the Food Triangle (#12).
The red factor in the B6J strain explained 17% of the variance and in D2J explained 23% of the variance and comprised an overlapping yet largely distinct set of variables between the two strains. For B6J mice, the red factor only comprised the three main compulsive behavior variables (#14, #15, and #16), including Light/Dark Time (#14), Light/Dark Entries (#15), an Light/Dark Distance (#16) and was termed “Compulsive-Like Activity.” For the D2J strain, in addition to these three variables, the red factor also contained D18 PF Intake (#2), D18 Time in Food Triangle (#3), D18 Distance in Food Triangle (#5), and Escalation Slope (#6) and for this reason, was termed “BE and Compulsive-Like Activity”.
The yellow factor in the B6J strain explained 19% of the variance in the D2J strain explained 15% of the variance and was also largely distinct between the two strains. For the B6J strain, the yellow factor was more extensive and contained 7 variables with loadings greater than 0.4 (#1, #2, #5, #6, #7, #11, and #13), including D2 PF Intake (#1), D18 PF Intake (#2), D18 Distance in Food Triangle (#5), Escalation Slope (#6), D22 Entries to the Food Side (#7), D22 Time in Food Triangle (#11), Light/Dark PF Intake (#13) and was termed “Generalized PF Intake and Seeking.” The generalized intake refers to the fact that acute D2 intake (prior to binge escalation) loaded onto a common intake factor in B6J mice.
The yellow factor in D2J mice accounted for less variance and only contained 4 variables with loadings greater than 0.4 (#4, #7, #8, #11) that also included D22 Entries to the Food Side (#7) and D22 Time in Food Triangle (#11) but also D18 Entries into the Food Triangle (#4) and D22 Time on the Food Side (#8). However, the yellow factor in D2J mice did not include any intake variables (those variables loaded onto the red factor) and thus, was termed “PF CPP” To summarize, the most striking finding from exploratory factor analysis of the parental strains was that for B6J mice, intake and concomitant activity variables loaded onto a single factor whereas in D2J mice, only some of the intake variables loaded onto a single factor which also contained subsequent compulsive-like behaviors.
We next conducted exploratory factor analysis in 133 F2 mice that segregated B6J and D2J alleles. The purpose of this analysis was to determine the extent to which variation among behavioral variables was co-inherited as evidenced by co-loading of variables onto a common factor versus independent inheritance as evidence by distinct loading onto separate factors. In F2 mice, three factors explained 52% of the total variance [χ2 (75, N = 133) = 456.4; p = 5.0 × 10−56; Fig. 7C].
The blue factor (#5, #7, #9, #10, and #12) in F2 mice accounted for 21% of the total variance and was similarly termed “Food Seeking Activity”, as it encompassed largely the same phenotypes as the parental strains (in particular B6J) related to activity in the food-paired side and the food triangle on the preference assessment day (D22) and additionally, D18 Distance in the Food Triangle.
The red factor (#14, #15, and #16) in F2 mice explained 16% of the variance and similar to the B6J strain was termed “Compulsive-Like Activity” as it encompassed the same activity measures in the light/dark apparatus.
The yellow factor (1,2,6,13) explained 15% of the variance, and was clearly distinct from two parental strains as it purely contained all of the intake phenotypes, including D2 Intake, D18 Intake, Escalation Slope, and Light/Dark Intake (D23). This factor was therefore termed “ BE”.
3.11. Exploratory factor analysis of premorbid compulsive/anxiety-like battery in F2mice
We also analyzed premorbid compulsive and anxiety-like behaviors separately in a subset of the F2 mice. Three factors explained 40% of the total variance [χ2 (88, N = 93) = 169.7; p = 3.9 × 10−7; Fig. 7D]. The purple factor explained 14% of the variance and consisted of behaviors in the hole board test. The green factor explained 14% of the variance, encompassed behaviors in the EPM test. The brown factor explained 11% of the variance and contained the two marble burying phenotypes. None of the open field variables or y-maze variables loaded onto any factor. Together, these results indicate that there is little overlap variance explained between the behavioral variables of the five assays comprising the anxiety/compulsive-like battery and suggest that the genetic basis of each assay is likely to be largely distinct. Furthermore, the lack of co-loading of any of these premorbid variables onto the BE ingestive and non-ingestive measures suggest that they are not genetically correlated with BE and thus, lack predictive value in this F2 cross.
4. DISCUSSION
We identified robust strain differences in BE, with the D2J strain but not the B6J strain exhibiting a dramatic escalation in PF consumption along with compulsive-like eating in the light-dark test (Figs.1-3). Consistent with our previous studies of BE in B6J mice [19] or WT littermates on a B6J background [26], B6J mice showed little evidence of BE in our intermittent, limited access paradigm of sweetened PF and correspondingly, showed no conditioned PF reward or compulsive-like eating (Figs.1,2). In examining the behavioral organization of BE and other behavioral measures in the parental strains, for the BE-resistant B6J strain, ingestive behaviors (yellow: #1, #2, #6) loaded onto a separate factor from light/dark activity (red; #14, #15, #16; Fig. 7A). In contrast, for the BE-prone D2J strain, neither initial PF intake (#1) nor compulsive-like eating (#13) loaded onto any factor whereas BE-level intake (D18) and slope of escalation loaded onto the same factor as compulsive-like activity - a factor that we termed “BE and Compulsive-Like Activity” for the D2J strain (red; Fig. 7B). Together, these findings that the unique hoarding-like behavior in the light/dark box in the D2J strain (Fig. 3) was reflective of the degree of BE (but not initial PF ingestion), whereas in B6J mice, simple initial intake was more predictive of future intake. In contrast to the parental strains, factor analysis in the F2 mice indicated that all PF intake variables, including intake on D2 and D18, slope of escalation, and compulsive-like intake, loaded cleanly onto a single factor (yellow; Fig. 7C). None of the premorbid anxiety/compulsive-like factors loaded onto any of the PF consumption phenotypes in the initial analysis (not shown) nor did they overlap in their factor loadings (Fig. 7D), suggesting a separate genetic basis from BE as well as a separate genetic basis for each of these premorbid assays.
Strain differences in BE could not be explained by initial differences in body weight as there was no difference on the first day of the training session (Fig. S2), yet there was already a marked increase in PF consumption in D2J mice (Fig. 1B; Fig. 4A,D; Fig. S1A). Furthermore, the D2J increase in PF intake was accompanied by reduced weight gain relative to Chow-trained D2J mice who gained significantly more weight (PF = 7.6% ± 1.1%; Chow = 11.6% ± 1.4%, t(45) = 2.2; p = 0.03; see Fig. S2). The observation that BE was associated with less percent change in BW is further supported by D2J females showing a 1.5-fold greater increase in % BW consumed compared to D2J males (Fig. 1C), yet showing a three-fold lower percent increase in % BW relative to male mice (Fig. 1E). To summarize, differences in body weight were not associated with the initial difference in PF consumption and the escalation in consumption was associated with a reduced % increase in BW. The latter conclusion is further supported by a negative correlation between the total % BW consumed and change in BW in F2 mice (r = −0.24; p = 0.006).
Similar to our previous studies [19, 26, 44], we normalized daily food intake to daily body weight to adjust for individual differences, strain differences, and sex differences and the potential correlation with consumption. We found trending correlations between body weight and raw grams of PF consumed on later training days in B6J [D16: r=0.36 (p=0.08)] and in D2J [D18: r=0.37 (p=0.076)], providing a rationale for the adjustment. Analysis of raw grams of PF consumed revealed similar results as we report with normalized PF consumption, namely increased binge eating in the D2J strain and an association of the chromosome 6 and chromosome 11 loci with changes in PF intake (data not shown). Whether or not the amount of food intake (i.e., the “binge size”) during a particular BE episode is related to body weight or body mass index (BMI) in humans is an area of investigation requiring additional research. One human experimental study showed a correlation between BMI and measured meal size specifically when BED participants were instructed to binge but not when BED participants were asked to eat normally [53]. No correlation was observed in obese or non-obese subjects without BED. Another study comprising self-report of both obese and non-obese BED participants found a significant correlation between both binge size and binge frequency with BMI [54].
It is interesting to note that despite the D2J strain exhibiting a large degree of compulsive-like consumption of PF, they nevertheless continued to exhibit marked avoidance/aversion for the light side of the light/dark box, showing less time, fewer entries, and a shorter average visit time that was similar to Chow- trained D2J mice (Fig. 3). This is in stark contrast to the BE-prone B6NJ strain (a closely related substrain of B6J) that exhibited an increase in compulsive-like eating, a decrease in avoidance behavior (increased time in the light side), an increase in visit time in the light side, and a concomitant fewer number of entries into the light side [19]. Clearly, the innate avoidance behavior in the D2J strain was not compromised by the profound, rapid consumption of the available PF in the open arena. In other words, the D2J strain managed to avoid the light side while at the same time, efficiently transport large amounts of PF to the safer environment where they consumed it. In support, horizontal video observation of a subset of the D2J strain confirmed that when D2J mice entered the light side, they exhibited a stretched posture and efficiently traveled as little distance as possible directly toward the food bowl, retrieved the PF, and immediately retreated back to the dark side to consume it (Fig. 3A,B; see also Supplementary Information for videos). Furthermore, the D2J strain showed a five-fold increase in the number of pellets retrieved per entry into the light (Fig. 3C). This behavior is in some ways reminiscent of hoarding behavior exhibited by many patients with BE [6, 55], including hoarding of food [56] with more severe hoarding behavior being associated with the presence of ED, in particular with females [57]. Hoarding may represent a behavioral strategy in addition to BE that could serve to alleviate negative emotions [55]. In humans, hoarding of food for BE is an adaptive behavior that serves to avoid the aversive social stigma associated with BE [58]. In the D2J strain, hoarding-like behavior was also adaptive since it permitted efficient intake of the PF that was on par with the amount exhibited during escalated consumption (Fig. 3B vs. Fig. 1B) without sacrificing any avoidance behavior of the aversive (and potentially dangerous) light environment. That escalated PF intake did not compete with innate avoidance behavior in PF- versus Chow-trained D2J mice is remarkable and illustrates the extreme motivation to obtain the PF and retreat as quickly as possible.
We are not aware of any other preclinical, forward genetic studies of BE besides our recent study [19]. However, there is an extensive literature on forward genetic studies of consumption of and preference for PF (e.g., sucrose and fat) in rodents and other animal species [59]. Variation in the hedonic score for sucrose shows a heritability of approximately 50% in adult humans [60], indicating a strong genetic component. Because we utilized the 5-TUL diet in which sucrose is the primary palatable ingredient, a discussion is warranted on the literature involving differences in sucrose consumption between B6J and D2J alleles [27–32, 61]. An important observation is that the length of access to sucrose can determine the directionality of strain difference in liquid sucrose consumption between B6J and D2J. Similar to our results, short-term access (2h or less) induced greater consumption in D2J [28] and longer-term access (6h or greater) induced greater consumption in B6J [27, 61, 62]. For the long-term access (B6J strain > D2J strain; opposite of our results), a QTL on distal chromosome 4 was identified [27] that was hypothesized to be mediated by one or more polymorphisms in the Tas13r gene [32, 61, 63]. However, there was no genetic correlation between short- and long-term consumption among inbred strains [28], suggesting that short- and long-term consumption are mediated by separate genetic factors.
We tested the effect of Genotype at the chromosome 4 Tas13r sweet taste locus on PF consumption in 133 B6J x D2J-F2 mice and were surprised to find no effect of Genotype at any time point in the BE training session (Fig. 5) TAS1R3 codes for one of three receptors of the TAS1R gene family (TAS1R1-TAS1R3). TAS1R3 dimerizes with either TAS1R1 or TAS1R2 to form the sweet receptor or the umami receptor, respectively [64]. Our negative results suggested that in our paradigm, polymorphisms at the Tas13r locus do not contribute (at least, not additively) to strain differences in acute or escalated PF intake of the 5-TUL diet in B6J versus D2J strains. It is possible that under different conditions (e.g., longer access to the 5-TUL diet) that this locus could affect acute or escalated PF intake. Alternatively, the locus could interact epistatically with other loci and we are not powered to detect epistatic interactions with our small sample size.
Unexpectedly, we found evidence that the second taste QTL on chromosome 6, the Tas2r locus that was previously associated with greater consumption of a bitter solution with the D2J allele [27], was associated with greater PF intake over time and compulsive-like intake in the light-dark test (Fig. 5D-F). The increased PF intake associated with the D2J allele was driven exclusively by males (D9, D16, D18, and compulsive-like eating; Fig. 6D-F) and the Tas2r locus accounted for 14% to 38% of the phenotypic variance and 31% to 60% of the genetic variance in D9, D16, and D18 PF intake and compulsive-like eating, respectively (Table 1). Sex differences in bitter taste detection have been reported in humans [65] and in rats which can fluctuate across the estrous cycle [66] and could contribute to the phenotypic variance in females. Future genome-wide studies in female mice that seek to identify female-specific QTLs accounting for the unexplained variance in BE should also monitor and account for variance due to estrus cycle [67]. Indeed, our null result for females on chromosome 6 could potentially be explained by variance due to estrus cycle masking the genotypic effect on PF intake.
The Tas2rlocus contains a cluster of 25 Tas2r genes that code for T2Rs that function as bitter taste receptors [34]. While there was no effect of Genotype on initial PF consumption at the Tas2r locus (Fig. 3D,E), there was an effect at later time points where mice homozygous for D2J consumed more PF on D9 and D16 as well as greater compulsive-like PF consumption compared to mice homozygous for B6J (Fig. 3D-F). Together, the results suggest that decreased sensitivity to bitter taste perception associated with the D2J allele could permit consumption of progressively larger amounts of sweetened PF. Or i.e., increased sensitivity to bitter taste associated with the B6J allele (reduced bitter consumption) could limit the escalation of PF consumption because of the bitterness itself and/or over-heightened the sweet perception of sucrose [68], thus limiting intake.
The association of the Tas2r locus with BE in our model has relevance for BE and eating disorders in humans [69]. Genetic influences on eating behaviors can potentially affect multiple biological processes that include taste processing and perception, palatability, liking/preference versus disliking/disgust/aversion, and/or potentially one or more neural circuits involved in energy homeostasis (hunger versus satiety) versus food motivation and reward [36, 70]. The genetic basis of eating disorders, and more specifically BE as a quantitative trait, is almost entirely unknown but polymorphisms in taste receptors could contribute to BE susceptibility. In support, a recent human genetic study identified a coding polymorphism within TAS2R38 that decreased sensitivity to bitter taste was associated with increased disinhibition of eating behavior in women of Amish descent [71]. Additionally, in line with our current results, increased preference for sweetened food has been linked to decreased perception of bitter taste [72]. TAS2R38 is a member of the bitter gene receptor family and accounts for up to 60–85% of the phenotypic variance in bitter sensitivity to synthetic pharmaceuticals [73].
Taste receptor polymorphisms are associated with the choice and amount of food that is consumed which can influence taste receptor physiology. Polymorphisms of several different TAS2R genes in humans are associated with an altered response to bitter taste stimuli and ingestive behaviors such as alcohol use and abuse [74, 75], vegetable consumption [76], and consumption of energy dense foods such as butter, beer, and cured meat [77]. Additionally, genetic variations in the sweet taste receptor TAS1R2 are associated with dietary sugar intake in overweight and obese populations [75]. The type and amount of food consumed has been shown to be altered in BED compared to obese controls, in that subjects with BED choose to consume more energy-dense foods such as red meat and sweet foods such as ice cream [78]. Together, polymorphisms in taste receptors influence food selection which could increase risk for BE. In addition to taste receptor polymorphisms affecting eating behaviors, disordered eating behaviors such as cycles of BE and food restriction can alter taste receptor function, thus acting as a vicious cycle to facilitate disordered eating. Both AN and BN have been associated with reduced brain response to an aversive bitter stimulus [79] as well as reduced perception of bitter taste [80], and AN, BN, and BED are associated with reduced taste papillae [81]. Thus, the progressive increase in PF consumption in the bitter taste-resistant D2J strain at the Tas2r locus [27] could further alter taste receptor physiology and further add to the reduced genetic effect on bitter perception, thus, exacerbating BE.
In addition to the Tas2r locus, the D2J allele at the chromosome 11 locus (50 Mb) was associated with an enhancement of PF intake (D18) as well as the slope of escalation (Fig. 5G,H). This locus accounted for 8% and 19% of the phenotypic variance as well as 8% and 26% of the genetic variance in D18 PF intake and slope of escalation, respectively. The effect was more pronounced in the males where 39% of the phenotypic variance and 73% of the genetic variance was captured by this locus (Fig. 6G-L). Using mice comprising B6J and D2J alleles, this locus was previously associated with intravenous cocaine self-administration and differential expression of the gene Cyfip2 [39], as well as methamphetamine-induced locomotor activity and the gene Hnrnphl [35, 40]. Thus, polymorphisms in either gene could potentially contribute to escalated consumption comprising BE, e.g., via modulation of the reward circuit function. In support, we previously mapped and validated Cyfip2 as a major genetic factor underlying BE in a reduced complexity cross between B6 substrains [19].
There are several limitations to this study. Despite a careful genetic analysis and assessment of reasonable candidate loci, this study lacks the unbiased nature of a genome-wide QTL scan. While our F2 study was not well-powered to detect genome-wide significant effects of QTLs of moderate effect size, it served as a reasonable preliminary investigation into the contribution of well-established taste and drug loci while at the same time assessing feasibility of conducting a genome- wide QTL analysis in a larger F2 cohort and employing the BXD genetic reference panel. Because of the small sample size, it is possible that our variance estimates are inaccurate. Hundreds of additional mice will need to be phenotyped (both PF and Chow pellets) and genotyped at a panel of markers to more accurately account for phenotypic variance and identify additional loci contributing to the various components of BE, in particular for females where a majority of the heritability remains unexplained.
To summarize, we identified a forward genetic model of BE that lays the groundwork and rationale for a future large-scale, well-powered forward genetic study, especially in female mice where more of the variance remains unexplained. The clear advantages offered by the genetic tools comprising alleles from the B6J and D2J parental strains, including the BXD RI panel [25], interval-specific congenics for fine mapping [82], and the wealth of phenotypic data on GeneNetwork [83, 84] ensure that a systems genetic approach with these powerful tools will likely yield new insight into the genetic, genomic, and neurobiological mechanisms of risk for BE as well as the neurobiological adaptations underlying the establishment of and recovery from BE which will inform new treatment strategies.
Supplementary Material
highlights.
DBA/2J mice show robust binge eating compared to the C57BL/6J mice.
DBA/2J anxiety-like behavior dictates the location of compulsive-like eating.
The DBA/2J allele at Tas2r is associated with increased binge eating in F2 males.
The DBA/2J allele at a chromosome 11 locus (50 Mb) is associated with binge eating.
Most of the phenotypic variance in binge eating in F2 females remains unexplained.
ACKNOWLEDGEMENTS
These studies were supported by NIDA grants R21DA038738 (C.D.B.) and R01DA039168 (C.D.B.). We would like to acknowledge the Analytical Instrumentation Core at Boston University School of Medicine (S10OD023663), including the Core Director, Dr. Lynn Lingyi Deng and the Lab Manager, Matthew Au.
Footnotes
Declarations of interest
None
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- [1].Smink FR, van Hoeken D, Hoek HW Epidemiology of eating disorders: Incidence, prevalence and mortality rates. Curr Psychiatry Rep. 2012, 14:406–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Yilmaz Z, Hardaway JA, Bulik CM Genetics and epigenetics of eating disorders. Adv Genomics Genet. 2015, 5:131–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Casper RC, Eckert ED, Halmi KA, Goldberg SC, Davis JM Bulimia. its incidence and clinical importance in patients with anorexia nervosa. Arch Gen Psychiatry. 1980, 37:1030–5. [DOI] [PubMed] [Google Scholar]
- [4].Wardle J, Beinart H Binge eating: A theoretical review. Br J Clin Psychol. 1981, 20:97–109. [DOI] [PubMed] [Google Scholar]
- [5].Wolfe BE, Baker CW, Smith AT, Kelly-Weeder S Validity and utility of the current definition of binge eating. Int J Eat Disord. 2009, 42:674–86. [DOI] [PubMed] [Google Scholar]
- [6].Novara C, Bottesi G, Dorz S, Sanavio E Hoarding symptoms are not exclusive to hoarders. Front Psychol. 2016, 7:1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].White MA, Grilo CM Diagnostic efficiency of DSM-IV indicators for binge eating episodes. J Consult Clin Psychol. 2011, 79:75–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Razzoli M, Pearson C, Crow S, Bartolomucci A Stress, overeating, and obesity: Insights from human studies and preclinical models. Neurosci Biobehav Rev 2017, 76:154–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Bosch A, Miltenberger RG, Gross A, Knudson P, Breitwieser CB Evaluation of extinction as a functional treatment for binge eating. Behav Modif. 2008, 32:556–76. [DOI] [PubMed] [Google Scholar]
- [10].de Jong JW, Meijboom KE, Vanderschuren LJ, Adan RA Low control over palatable food intake in rats is associated with habitual behavior and relapse vulnerability: Individual differences. PLoS One. 2013, 8:e74645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Fairburn CG, Cooper Z, Doll HA, Norman P, O’Connor M The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry. 2000, 57:659–65. [DOI] [PubMed] [Google Scholar]
- [12].Olmsted MP, MacDonald DE, McFarlane T, Trottier K, Colton P Predictors of rapid relapse in bulimia nervosa. Int J Eat Disord. 2015, 48:337–40. [DOI] [PubMed] [Google Scholar]
- [13].Jasinski DR, Krishnan S Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J Psychopharmacol. 2009, 23:419–27. [DOI] [PubMed] [Google Scholar]
- [14].Reas DL, Grilo CM Pharmacological treatment of binge eating disorder: Update review and synthesis. Expert Opin Pharmacother. 2015, 16:1463–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].McElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2016, 41:1251–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Schreiber LR, Odlaug BL, Grant JE The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology. J Behav Addict. 2013, 2:191–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Schulte EM, Grilo CM, Gearhardt AN Shared and unique mechanisms underlying binge eating disorder and addictive disorders. Clin Psychol Rev. 2016, 44:125–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Davis C The epidemiology and genetics of binge eating disorder (BED). CNS Spectr 2015, 20:522–9. [DOI] [PubMed] [Google Scholar]
- [19].Kirkpatrick SL, Goldberg LR, Yazdani N, Babbs RK, Wu J, Reed ER, Jenkins DF, Bolgioni AF, Landaverde KI, Luttik KP, Mitchell KS, Kumar V, Johnson WE, Mulligan MK, Cottone P, Bryant CD Cytoplasmic FMR1-interacting protein 2 is a major genetic factor underlying binge eating. Biol Psychiatry. 2017, 81:757–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Corwin RL Bingeing rats: A model of intermittent excessive behavior?. Appetite. 2006, 46:11–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Corwin RL, Babbs RK Rodent models of binge eating: Are they models of addiction?. ILAR J 2012, 53:23–34. [DOI] [PubMed] [Google Scholar]
- [22].Bryant CD The blessings and curses of C57BL/6 substrains in mouse genetic studies. Ann N Y Acad Sci. 2011, 1245:31–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Kumar V, Kim K, Joseph C, Kourrich S, Yoo SH, Huang HC, Vitaterna MH, de Villena FP, Churchill G, Bonci A, Takahashi JS C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science. 2013, 342:1508–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Zhou Z, Karlsson C, Liang T, Xiong W, Kimura M, Tapocik JD, Yuan Q, Barbier E, Feng A, Flanigan M, Augier E, Enoch MA, Hodgkinson CA, Shen PH, Lovinger DM, Edenberg HJ, Heilig M, Goldman D Loss of metabotropic glutamate receptor 2 escalates alcohol consumption. Proc Natl Acad Sci U S A. 2013, 110:16963–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains. Genes Brain Behav. 2010, 9:129–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Goldberg LR, Kirkpatrick SL, Yazdani N, Luttik KP, Lacki OA, Babbs RK, Jenkins DF, Johnson WE, Bryant CD Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating. Genes Brain Behav. 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Blizard DA, Kotlus B, Frank ME Quantitative trait loci associated with short-term intake of sucrose, saccharin and quinine solutions in laboratory mice. Chem Senses. 1999, 24:373–85. [DOI] [PubMed] [Google Scholar]
- [28].Dym CT, Pinhas A, Ginzberg M, Kest B, Bodnar RJ Genetic variance contributes to naltrexone-induced inhibition of sucrose intake in inbred and outbred mouse strains. Brain Res. 2007, 1135:136–45. [DOI] [PubMed] [Google Scholar]
- [29].Dym CT, Pinhas A, Robak M, Sclafani A, Bodnar RJ Genetic variance contributes to dopamine receptor antagonist-induced inhibition of sucrose intake in inbred and outbred mouse strains. Brain Res. 2009, 1257:40–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Lewis SR, Ahmed S, Dym C, Khaimova E, Kest B, Bodnar RJ Inbred mouse strain survey of sucrose intake. Physiol Behav. 2005, 85:546–56. [DOI] [PubMed] [Google Scholar]
- [31].Pinhas A, Aviel M, Koen M, Gurgov S, Acosta V, Israel M, Kakuriev L, Guskova E, Fuzailov I, Touzani K, Sclafani A, Bodnar RJ Strain differences in sucrose- and fructose-conditioned flavor preferences in mice. Physiol Behav. 2012, 105:451–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Reed DR, Li S, Li X, Huang L, Tordoff MG, Starling-Roney R, Taniguchi K, West DB, Ohmen JD, Beauchamp GK, Bachmanov AA Polymorphisms in the taste receptor gene (Tas1r3) region are associated with saccharin preference in 30 mouse strains. J Neurosci. 2004, 24:938–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Li X, Inoue M, Reed DR, Huque T, Puchalski RB, Tordoff MG, Ninomiya Y, Beauchamp GK, Bachmanov AA High-resolution genetic mapping of the saccharin preference locus (sac) and the putative sweet taste receptor (T1R1) gene (Gpr70) to mouse distal chromosome 4. Mamm Genome. 2001, 12:13–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Nelson TM, Munger SD, Boughter JD Jr. Haplotypes at the Tas2r locus on distal chromosome 6 vary with quinine taste sensitivity in inbred mice. BMC Genet. 2005, 6:32,2156–6–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [35].Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD Hnrnph1 is A quantitative trait gene for methamphetamine sensitivity. PLoS Genet. 2015, 11:e1005713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36].DiLeone RJ, Taylor JR, Picciotto MR The drive to eat: Comparisons and distinctions between mechanisms of food reward and drug addiction. Nat Neurosci. 2012, 15:1330–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].Babbs RK, Wojnicki FH, Corwin RL Assessing binge eating. an analysis of data previously collected in bingeing rats. Appetite. 2012, 59:478–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Bachmanov AA, Li X, Reed DR, Ohmen JD, Li S, Chen Z, Tordoff MG, de Jong PJ, Wu C, West DB, Chatterjee A, Ross DA, Beauchamp GK Positional cloning of the mouse saccharin preference (sac) locus. Chem Senses. 2001, 26:925–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [39].Dickson PE, Miller MM, Calton MA, Bubier JA, Cook MN, Goldowitz D, Chesler EJ, Mittleman G Systems genetics of intravenous cocaine self-administration in the BXD recombinant inbred mouse panel. Psychopharmacology (Berl). 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [40].Parker CC, Cheng R, Sokoloff G, Palmer AA Genome-wide association for methamphetamine sensitivity in an advanced intercross mouse line. Genes Brain Behav. 2012, 11:52–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41].Moore CF, Sabino V, Koob GF, Cottone P Pathological overeating: Emerging evidence for a compulsivity construct. Neuropsychopharmacology. 2017, 42:1375–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42].Micali N, Hilton K, Nakatani E, Heyman I, Turner C, Mataix-Cols D Is childhood OCD a risk factor for eating disorders later in life? A longitudinal study. Psychol Med 2011, 41:2507–13. [DOI] [PubMed] [Google Scholar]
- [43].Cavallini MC, Bertelli S, Chiapparino D, Riboldi S, Bellodi L Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder. Am J Med Genet. 2000, 96:384–91. [DOI] [PubMed] [Google Scholar]
- [44].Babbs RK, Ruan QT, Kelliher JC, Feng AX, Kirkpatrick SL, Benitez FA, Rodriguez FA, Pierre J, Kumar V, Mulligan MK, Bryant CD Cyfip1 haploinsufficiency increases compulsive-like behavior and paternally inherited palatable food intake: Implications for prader-willi syndrome. BioRxiv. 2018. [Google Scholar]
- [45].Hegmann JP, Possidente B Estimating genetic correlations from inbred strains. Behav Genet. 1981, 11:103–14. [DOI] [PubMed] [Google Scholar]
- [46].Falconer DS, Mackay TFC, ed. Introduction to Quantitative Genetics 4th ed Burnt Mill, England, U.K.: Longman, 1996. [Google Scholar]
- [47].Kirkpatrick SL, Bryant CD Behavioral architecture of opioid reward and aversion in C57BL/6 substrains. Front Behav Neurosci. 2015, 8:450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [48].Faul F, Erdfelder E, Lang AG, Buchner A G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007, 39:175–91. [DOI] [PubMed] [Google Scholar]
- [49].Berner LA, Avena NM, Hoebel BG Bingeing, self-restriction, and increased body weight in rats with limited access to a sweet-fat diet. Obesity (Silver Spring). 2008, 16:1998–2002. [DOI] [PubMed] [Google Scholar]
- [50].Cottone P, Sabino V, Steardo L, Zorrilla EP Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Neuropsychopharmacology. 2008, 33:524–35. [DOI] [PubMed] [Google Scholar]
- [51].Milner LC, Crabbe JC Three murine anxiety models: Results from multiple inbred strain comparisons. Genes Brain Behav. 2008, 7:496–505. [DOI] [PubMed] [Google Scholar]
- [52].Sokoloff G, Parker CC, Lim JE, Palmer AA Anxiety and fear in a cross of C57BL/6J and DBA/2J mice: Mapping overlapping and independent QTL for related traits. Genes Brain Behav. 2011, 10:604–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [53].Guss JL, Kissileff HR, Devlin MJ, Zimmerli E, Walsh BT Binge size increases with body mass index in women with binge-eating disorder. Obes Res. 2002, 10:1021–9. [DOI] [PubMed] [Google Scholar]
- [54].Picot AK, Lilenfeld LR The relationship among binge severity, personality psychopathology, and body mass index. Int J Eat Disord. 2003, 34:98–107. [DOI] [PubMed] [Google Scholar]
- [55].Raines AM, Boffa JW, Allan NP, Short NA, Schmidt NB Hoarding and eating pathology: The mediating role of emotion regulation. Compr Psychiatry. 2015, 57:29–35. [DOI] [PubMed] [Google Scholar]
- [56].Hagan MM, Wauford PK, Chandler PC, Jarrett LA, Rybak RJ, Blackburn K A new animal model of binge eating: Key synergistic role of past caloric restriction and stress. Physiol Behav. 2002, 77:45–54. [DOI] [PubMed] [Google Scholar]
- [57].Wheaton M, Timpano KR, Lasalle-Ricci VH, Murphy D Characterizing the hoarding phenotype in individuals with OCD: Associations with comorbidity, severity and gender. J Anxiety Disord. 2008, 22:243–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [58].Smith DG, Robbins TW The neurobiological underpinnings of obesity and binge eating: A rationale for adopting the food addiction model. Biol Psychiatry. 2013, 73:804–10. [DOI] [PubMed] [Google Scholar]
- [59].Boughter JD Jr, Bachmanov AA. Behavioral genetics and taste. BMC Neurosci. 2007, 8 Suppl 3:S3,2202–8-S3-S3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [60].Keskitalo K, Knaapila A, Kallela M, Palotie A, Wessman M, Sammalisto S, Peltonen L, Tuorila H, Perola M Sweet taste preferences are partly genetically determined: Identification of a trait locus on chromosome 16. Am J Clin Nutr. 2007, 86:55–63. [DOI] [PubMed] [Google Scholar]
- [61].Glendinning JI, Chyou S, Lin I, Onishi M, Patel P, Zheng KH Initial licking responses of mice to sweeteners: Effects of tas1r3 polymorphisms. Chem Senses. 2005, 30:601–14. [DOI] [PubMed] [Google Scholar]
- [62].Kotlus BS, Blizard DA Measuring gustatory variation in mice: A short¬term fluid-intake test. Physiol Behav. 1998, 64:37–47. [DOI] [PubMed] [Google Scholar]
- [63].Montmayeur JP, Liberles SD, Matsunami H, Buck LB A candidate taste receptor gene near a sweet taste locus. Nat Neurosci. 2001, 4:492–8. [DOI] [PubMed] [Google Scholar]
- [64].Feeney E, O’Brien S, Scannell A, Markey A, Gibney ER Genetic variation in taste perception: Does it have a role in healthy eating?. Proc Nutr Soc. 2011, 70:135–43. [DOI] [PubMed] [Google Scholar]
- [65].Yoshinaka M, Ikebe K, Uota M, Ogawa T, Okada T, Inomata C, Takeshita H, Mihara Y, Gondo Y, Masui Y, Kamide K, Arai Y, Takahashi R, Maeda Y Age and sex differences in the taste sensitivity of young adult, young-old and old-old japanese. Geriatr Gerontol Int. 2016, 16:1281–8. [DOI] [PubMed] [Google Scholar]
- [66].Clarke SN, Ossenkopp KP Taste reactivity responses in rats: Influence of sex and the estrous cycle. Am J Physiol. 1998, 274:R718–24. [DOI] [PubMed] [Google Scholar]
- [67].Klump KL, Culbert KM, Sisk CL Sex differences in binge eating: Gonadal hormone effects across development. Annu Rev Clin Psychol. 2017. [DOI] [PubMed] [Google Scholar]
- [68].Lucchina LA, Curtis OF, 5., Putnam P, Drewnowski A., Prutkin JM, Bartoshuk LM. Psychophysical measurement of 6-n-propylthiouracil (PROP) taste perception. Ann N Y Acad Sci. 1998, 855:816–9. [DOI] [PubMed] [Google Scholar]
- [69].Grimm ER, Steinle NI Genetics of eating behavior: Established and emerging concepts. Nutr Rev. 2011, 69:52–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [70].de Krom M, Bauer F, Collier D, Adan RA, la Fleur SE Genetic variation and effects on human eating behavior. Annu Rev Nutr. 2009, 29:283–304. [DOI] [PubMed] [Google Scholar]
- [71].Dotson CD, Shaw HL, Mitchell BD, Munger SD, Steinle NI Variation in the gene TAS2R38 is associated with the eating behavior disinhibition in old order amish women. Appetite. 2010, 54:93–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [72].Drewnowski A, Henderson SA, Shore AB, Barratt-Fornell A Nontasters, tasters, and supertasters of 6-n-propylthiouracil (PROP) and hedonic response to sweet. Physiol Behav. 1997, 62:649–55. [DOI] [PubMed] [Google Scholar]
- [73].Hansen JL, Reed DR, Wright MJ, Martin NG, Breslin PA Heritability and genetic covariation of sensitivity to PROP, SOA, quinine HCl, and caffeine. Chem Senses. 2006, 31:403–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [74].Wang JC, Hinrichs AL, Bertelsen S, Stock H, Budde JP, Dick DM, Bucholz KK, Rice J, Saccone N, Edenberg HJ, Hesselbrock V, Kuperman S, Schuckit MA, Bierut LJ, Goate AM Functional variants in TAS2R38 and TAS2R16 influence alcohol consumption in high-risk families of african-american origin. Alcohol Clin Exp Res. 2007, 31:209–15. [DOI] [PubMed] [Google Scholar]
- [75].Eny KM, Wolever TM, Corey PN, El-Sohemy A Genetic variation in TAS1R2 (Ile191Val) is associated with consumption of sugars in overweight and obese individuals in 2 distinct populations. Am J Clin Nutr. 2010, 92:1501–10. [DOI] [PubMed] [Google Scholar]
- [76].Duffy VB, Hayes JE, Davidson AC, Kidd JR, Kidd KK, Bartoshuk LM Vegetable intake in college-aged adults is explained by oral sensory phenotypes and TAS2R38 genotype. Chemosens Percept. 2010, 3:137–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [77].Perna S, Riva A, Nicosanti G, Carrai M, Barale R, Vigo B, Allegrini P, Rondanelli M Association of the bitter taste receptor gene TAS2R38 (polymorphism RS713598) with sensory responsiveness, food preferences, biochemical parameters and body-composition markers. A cross-sectional study in italy. Int J Food Sci Nutr. 2018, 69:245–52. [DOI] [PubMed] [Google Scholar]
- [78].Cooke EA, Guss JL, Kissileff HR, Devlin MJ, Walsh BT Patterns of food selection during binges in women with binge eating disorder. Int J Eat Disord. 1997, 22:187–93. [DOI] [PubMed] [Google Scholar]
- [79].Monteleone AM, Monteleone P, Esposito F, Prinster A, Volpe U, Cantone E, Pellegrino F, Canna A, Milano W, Aiello M, Di Salle F, Maj M Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study. J Psychiatr Res. 2017, 90:94–101. [DOI] [PubMed] [Google Scholar]
- [80].Dazzi F, Nitto SD, Zambetti G, Loriedo C, Ciofalo A Alterations of the olfactory-gustatory functions in patients with eating disorders. Eur Eat Disord Rev. 2013, 21:382–5. [DOI] [PubMed] [Google Scholar]
- [81].Wockel L, Jacob A, Holtmann M, Poustka F Reduced number of taste papillae in patients with eating disorders. J Neural Transm (Vienna). 2008, 115:537–44. [DOI] [PubMed] [Google Scholar]
- [82].Iakoubova OA, Olsson CL, Dains KM, Ross DA, Andalibi A, Lau K, Choi J, Kalcheva I, Cunanan M, Louie J, Nimon V, Machrus M, Bentley LG, Beauheim C, Silvey S, Cavalcoli J, Lusis AJ, West DB Genome-tagged mice (GTM): Two sets of genome-wide congenic strains. Genomics. 2001, 74:89–104. [DOI] [PubMed] [Google Scholar]
- [83].Chesler EJ, Lu L, Wang J, Williams RW, Manly KF WebQTL: Rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nature neuroscience. 2004, 7:485–6. [DOI] [PubMed] [Google Scholar]
- [84].Chesler EJ, Wang J, Lu L, Qu Y, Manly KF, Williams RW Genetic correlates of gene expression in recombinant inbred strains: A relational model system to explore neurobehavioral phenotypes. Neuroinformatics. 2003, 1:343–57. [DOI] [PubMed] [Google Scholar]
- [85].Deacon RM Digging and marble burying in mice: Simple methods for in vivo identification of biological impacts. Nat Protoc. 2006, 1:122–4. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.